Company intelligence / Profile preview

Hyperfine

Guilford, Connecticut, United Stateshyperfine.io ↗

Ownership: Public · HYPR
Development stage: Commercial

Overview

Hyperfine’s Swoop system is the first FDA-cleared portable, ultra-low-field magnetic resonance brain imaging device. It enables bedside neuroimaging for patients of all ages and has received CE certification in the EU and UKCA certification in the UK. The company continues to advance image quality with AI-powered software and supports clinical studies such as NEURO PMR to validate utility in neurology offices.

Therapeutic areas: Neurology
Modalities: DeviceArtificial intelligence-powered imaging system
Industry: Medical Imaging

Partnerships

DENT Neurologic InstituteTexas NeurologyHealthCor Catalio Acquisition Corp.J.P. Morgan

Financials

Market cap: $66.6M
Total revenue: $3.9M
Enterprise value: $36.6M

Beyond the preview

Go deeper on Hyperfine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyperfine.

Explore the full profile